Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)

China flag China · Delayed Price · Currency is CNY
12.70
-0.17 (-1.32%)
At close: Jun 6, 2025, 2:57 PM CST
-6.69%
Market Cap 28.32B
Revenue (ttm) 5.53B
Net Income (ttm) 1.34B
Shares Out 2.23B
EPS (ttm) 0.60
PE Ratio 21.16
Forward PE 18.27
Dividend 0.27 (2.10%)
Ex-Dividend Date Jun 10, 2025
Volume 22,470,537
Average Volume 57,923,412
Open 12.83
Previous Close 12.87
Day's Range 12.64 - 12.93
52-Week Range 10.41 - 16.58
Beta 0.19
RSI 49.94
Earnings Date Aug 18, 2025

About SHE:301301

Yili Chuanning Biotechnology Co.,Ltd. engages in the research and development, and industrialization of biological fermentation technology in China. The company offers antibiotic intermediates, such as erythromycin thiocyanate, penicillin G potassium salt, 6-aminopenicillanic acid, 7-aminocephalosporanic acid, 7-aminodesacetoxycephalosporanic acid, and ursodeoxycholic acid. Yili Chuanning Biotechnology Co.,Ltd. was incorporated in 2010 and is based in Yining, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 3,184
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301301
Full Company Profile

Financial Performance

In 2024, SHE:301301's revenue was 5.76 billion, an increase of 19.38% compared to the previous year's 4.82 billion. Earnings were 1.40 billion, an increase of 48.88%.

Financial Statements

News

There is no news available yet.